Literature DB >> 20876615

A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene.

Fabienne Schaller1, Françoise Watrin, Rachel Sturny, Annick Massacrier, Pierre Szepetowski, Françoise Muscatelli.   

Abstract

The onset of feeding at birth is a vital step for the adaptation of the neonate to extra uterine life. Prader-Willi syndrome (PWS) is a complex neurogenetic disorder caused by the alteration of several imprinted contiguous genes including MAGEL2. PWS presents with various clinical manifestations, including poor suckling behaviour and feeding problems in neonates. Hypothalamic defects have been proposed, but the pathophysiological mechanisms remain poorly understood. Here, we report that a Magel2-deficient mouse with 50% neonatal mortality had an altered onset of suckling activity and subsequent impaired feeding, suggesting a role of MAGEL2 in the suckling deficit seen in PW newborns. The hypothalamus of Magel2 mutant neonates showed a significant reduction in oxytocin (OT). Furthermore, injection of a specific OT receptor antagonist in wild-type neonates recapitulated the feeding deficiency seen in Magel2 mutants, and a single injection of OT, 3-5 h after birth, rescued the phenotype of Magel2 mutant pups, allowing all of them to survive. Our study illustrates the crucial role of feeding onset behaviour after birth. We propose that OT supply might constitute a promising avenue for the treatment of feeding difficulties in PW neonates and potentially of other newborns with impaired feeding onset.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876615     DOI: 10.1093/hmg/ddq424

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  70 in total

1.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

Review 2.  The evolutionary biology of child health.

Authors:  Bernard Crespi
Journal:  Proc Biol Sci       Date:  2011-02-02       Impact factor: 5.349

3.  Oxytocin Treatment May Improve Infant Feeding and Social Skills in Prader-Willi Syndrome.

Authors:  Nancie J MacIver
Journal:  Pediatrics       Date:  2017-02       Impact factor: 7.124

Review 4.  Post-natal imprinting: evidence from marsupials.

Authors:  J M Stringer; A J Pask; G Shaw; M B Renfree
Journal:  Heredity (Edinb)       Date:  2014-03-05       Impact factor: 3.821

Review 5.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

6.  Oxytocin receptor gene loss influences expression of the oxytocin gene in C57BL/6J mice in a sex- and age-dependent manner.

Authors:  Radhika Vaidyanathan; Elizabeth A D Hammock
Journal:  J Neuroendocrinol       Date:  2020-02-11       Impact factor: 3.627

7.  Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Raena D Sumiyoshi; Lisa P Jackson; Debra S Karhson; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Joseph P Garner; Antonio Y Hardan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

Review 8.  Role of genomic imprinting in mammalian development.

Authors:  Thushara Thamban; Viplove Agarwaal; Sanjeev Khosla
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

Review 9.  The role of imprinted genes in fetal growth abnormalities.

Authors:  Jorge A Piedrahita
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-06-06

10.  Plasma Oxytocin and Arginine-Vasopressin Levels in Children with Autism Spectrum Disorder in China: Associations with Symptoms.

Authors:  Hong-Feng Zhang; Yu-Chuan Dai; Jing Wu; Mei-Xiang Jia; Ji-Shui Zhang; Xiao-Jing Shou; Song-Ping Han; Rong Zhang; Ji-Sheng Han
Journal:  Neurosci Bull       Date:  2016-06-24       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.